SeraCare's Seraseq Solid Tumor Mutation Mix-II Products
SeraCare Life Sciences has launched its Seraseq Solid Tumor Mutation Mix-II products. This includes eight new products that contain a total of 40 hard-to-sequence variants that increases the number of insertion-deletion mutations from four to 13. Additionally, the products include two DNA-level structural variants of actionable gene fusions. The company is now providing a single-tube blended reference material format that contains all 40 variants in a tri-level configuration with mutations of 10 percent, seven percent, or four percent allelic frequencies, the company said.
Agena's iPlex HS
Agena Bioscience has launched its iPlex HS, a new chemistry that enables highly sensitive, multiplexed detection of genetic variants present in solid tumors. It is ideal for targeted genotyping of tumor biopsies where high sensitivity is critical and sample quantity is limited, such as with heterogenous tumor and formalin-fixed tissue, the company said. The new chemistry enables detection of genetic variants that are present at frequency levels as low as one percent, the company said. The chemistry is run on the company's MassArray system.
GenBank 213 is now available via ftp from the National Center for Biotechnology Information. Uncompressed flatfiles in this release require 771 gigabytes for sequence files only. The ASN.1 data requires approximately 633 GB.
For more new products and services, please visit the New Products page on our website.